Nomograms for prostate cancer—is their use evidence-based?
- 1 October 2005
- journal article
- Published by Springer Science and Business Media LLC in Nature Reviews Endocrinology
- Vol. 2 (10), 462-463
- https://doi.org/10.1038/ncpuro0300
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?Journal of Urology, 2004
- VALIDATION OF THE KATTAN PREOPERATIVE NOMOGRAM FOR PROSTATE CANCER RECURRENCE USING A COMMUNITY BASED COHORT: RESULTS FROM CANCER OF THE PROSTATE STRATEGIC UROLOGICAL RESEARCH ENDEAVOR (CAPSURE)Journal of Urology, 2004
- PERCENT OF CORES POSITIVE FOR CANCER IS A BETTER PREOPERATIVE PREDICTOR OF CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY THAN PROSTATE SPECIFIC ANTIGENJournal of Urology, 2004
- Time trends in case selection, stage and prostate-specific antigen recurrence after radical prostatectomy: a multicentre auditBJU International, 2004
- A Preoperative Nomogram Identifying Decreased Risk of Positive Pelvic Lymph Nodes in Patients With Prostate CancerJournal of Urology, 2003
- Predicting clinical end points: treatment nomograms in prostate cancerSeminars in Oncology, 2003
- Prediction of Progression: Nomograms of Clinical UtilityClinical Prostate Cancer, 2002
- Making decisions about treatment for localized prostate cancerBJU International, 2002
- Combination of Prostate-Specific Antigen, Clinical Stage, and Gleason Score to Predict Pathological Stage of Localized Prostate CancerJAMA, 1997